Bifidobacterium bifidum-derived nanoparticles attenuate alcoholic liver disease via enhanced hepatic phagocytosis and gastrointestinal homeostasis

Accession: MTBLS12612
Source / host: MetaboLights — EMBL-EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform:
Organism: unspec
Size (indexed): 296.5 KB (303585 bytes)
Downloaded bytes: 296.5 KB (303585 bytes)
Access / raw: public / OPEN-processed

Download

Files

FileSizeSHA256
MTBLS12612.announcement.json32.3 KB19eee80700077c70…
MTBLS12612.mhd.json236.6 KB4886c5c270893850…
a_MTBLS12612_LC-MS_positive_reverse-phase_metabolite_profiling.txt10.9 KB2cc5ef2a1adbc14b…
i_Investigation.txt10.9 KB79f17556dbd45db9…
m_MTBLS12612_LC-MS_positive_reverse-phase_metabolite_profiling_v2_maf.tsv1.4 KB565fdeeed5cdef0e…
s_MTBLS12612.txt4.3 KB41fa7f247c938003…

Index note: processed layer (ISA-Tab+MAF); 6 files 296.5 KB

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T04:25:02Z.

About this dataset

This 10x Genomics dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.